Pure Global AI
NCT06316128Recruitment Completed

EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

Heart Care FoundationClinicalTrials.gov
Verified
Study focus
Disease/Condition
Acute Coronary Syndrome
Study type
Observational
Sponsor & location
Primary sponsor
Heart Care Foundation
Location
Casale,Ancona,Ancona,Arezzo,Montevarchi,Avellino,Acquaviva Delle Fonti,Altamura,Bari,Bari,Carbonara Di Bari,Seriate,Treviglio,Ponderano,Feltre,Bentivoglio,Bologna,Bologna,Brindisi,Brescia,Chiari,Desen, Italy
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Mar 29, 2024
Enrollment
3000 participants
Primary outcome

Antithrombotic therapies

Summary

This registry has the aim to assess the use of different antithrombotic therapies, including
 untested drug combinations, routinely used during the hospitalization phase, with their
 timing, route and dose of administration, in consecutive patients discharged with a diagnosis
 NSTEMI or STEMI in Italian Cardiac care Units (CCUs) during a four-week study period.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionAcute ischaemic heart disease, unspecifiedOther acute ischaemic heart diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06316128
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06316128 through Pure Global AI's free database. This phase not specified trial is sponsored by Heart Care Foundation and is currently Recruitment Completed. The study focuses on Acute Coronary Syndrome. Target enrollment is 3000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.